COXSACKIE MYOCARDITIS AND VIRAL PERSISTENCE IN THE HEART

柯萨奇心肌炎和病毒在心脏中的持续存在

• 批准号: 6137241
• 负责人: J. Lindsay Whitton
• 金额: $ 31.22万
• 依托单位: SCRIPPS RESEARCH INSTITUTE, THE
• 依托单位国家: 美国
• 财政年份: 1998
• 资助国家: 美国
• 起止时间: 1998-01-01 至 2002-12-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/6137241
• 关键词: B lymphocyte; CD4 molecule; CD8 molecule; CD95 molecule; Coxsackievirus; antiviral antibody; cell line; cellular immunity; cytotoxic T lymphocyte; disease /disorder model; helper T lymphocyte; humoral immunity; immunocytochemistry; laboratory mouse; myocarditis; nonhuman therapy evaluation; vaccinia virus; virus antigen; virus infection mechanism; virus protein; virus replication

Coxsackieviruses, members of the picornavirus family, are important human pathogens. Coxsackievirus B3 (CVB3), is a common associated factor in human subacute, acute, and chronic myocarditis. In young adults CVB3 infections may cause cardiac arrhythmias and acute heart failure; and chronic disease may supervene, leading to dilated cardiomyopathy, requiring transplantation, or to death. To better understand the pathogenesis of this disease, several mouse model systems have been established, which appear to parallel many aspects of the human disease process. We have begun to investigate the mechanisms underlying CVB myocarditis. The goals of this proposal are: 1. To further investigate the immune determinants of CVB3 myocarditis. What viral proteins do CD4+ and CD8+ T cells recognize, and how do these cells interact? Is the Fas pathway involved in disease? 2. To investigate the roles of antibodies and T cells in control of CVB3 infection and disease. Which virus proteins can protect against CVB? Is priming of CD8+ T-cell immunity beneficial or harmful? 3. To determine the cells infected during acute and persistent CVB3 infection. Does CVB interact with B cells early in infection? What other cells are infected? What cells are infected during virus persistence? 4. To begin evaluation of the nature of persistent CVB3. We have developed a system in which persistently-infected mice contain high levels of infectious virus. Does this persisting virus differ from the original? 5. To evaluate treatments for persistent CVB3 infection. Antibody- deficient humans often suffer from chronic picornavirus infections, which are frequently refractory to treatment. Our mouse model of persistence in the absence of B cells will be used for testing different treatment regimens.

柯萨奇病毒是小核糖核酸病毒家族的成员， 人类病原体 柯萨奇病毒B3（CVB 3）是一种常见的相关病毒， 人类亚急性、急性和慢性心肌炎中的因子。 年轻 成人CVB 3感染可引起心律失常和急性心脏病 失败;和慢性疾病可能随之而来，导致扩张 心肌病，需要移植，或死亡。 更好地 了解这种疾病的发病机制，几种小鼠模型系统 似乎与《公约》的许多方面平行， 人类疾病的过程。 我们已经开始研究 潜在的CVB心肌炎。 该提案的目标是：1。 到 进一步研究CVB 3心肌炎的免疫决定因素。 什么 CD 4+和CD 8 + T细胞识别的病毒蛋白，以及这些蛋白是如何识别的？ 细胞相互作用？ Fas通路与疾病有关吗？ 2. 到 研究抗体和T细胞在控制CVB 3中的作用 感染和疾病。哪些病毒蛋白可以预防CVB？ 引发CD 8 + T细胞免疫是有益还是有害？ 3. 到 确定急性和持续CVB 3感染期间感染的细胞。 CVB在感染早期是否与B细胞相互作用？ 其他细胞是什么 感染了吗 在病毒持续存在期间，哪些细胞会被感染？4. 到 开始评价持续性CVB 3的性质。 我们已经开发 一个系统，其中持续感染的小鼠含有高水平的 传染性病毒 这种持续存在的病毒与原来的不同吗？ 5. 评价持续性CVB 3感染的治疗方法。 抗体- 缺陷型人类经常遭受慢性小核糖核酸病毒感染， 其通常难以治疗。 我们的小鼠模型 在不存在B细胞的情况下的持久性将用于测试不同的 治疗方案。